Clinical Trials
727 trialsNutrition Intervention Trials in Linxian Follow-up Study
National Institutes of Health Clinical Center (CC)
ELEVATE
University of Southampton
Predicting Disease Progression and/or Recurrence in Cancer
Massachusetts General Hospital
FREGAT I
University Hospital, Lille
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Cybrexa Therapeutics
A Single-center, Single-arm Clinical Study Evaluating the Short-term Efficacy of Inflatable Mediastinoscopic-assisted Transhiatal Laparoscopic Esophagectomy for the Radical Resection of Thoracic Esophageal Cancer
Sun Yat-sen University
Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis
Sichuan University
Open Versus Laparoscopically-assisted Esophagectomy for Cancer
University Hospital, Lille
Shanghai Clinical Cohort - Esophageal Cancer
Shanghai Chest Hospital
RAMPART
Montefiore Medical Center
OPTIC
University Medical Center Groningen
TraveraRTGx
Travera Inc
SKYSCRAPER-08
Hoffmann-La Roche
Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial
University Hospital, Rouen
Esophageal Cancer in Northeastern Iran
National Institutes of Health Clinical Center (CC)
Esophageal Cancer Genetics Studies
National Institutes of Health Clinical Center (CC)
PROTECT
Centre Oscar Lambret
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
Washington University School of Medicine
ESCAPE
IRCCS San Raffaele
Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea
Tianjin Medical University Cancer Institute and Hospital
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Intima Bioscience, Inc.
TOX-FRAIL
Ankara Etlik City Hospital
ISCON
UMC Utrecht
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
National Cancer Institute (NCI)
Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19
Institute of Oncology Ljubljana
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
Tianjin Medical University Cancer Institute and Hospital
Esophageal Cancer Multimodal Prehabilitation Study
Massachusetts General Hospital
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy
The Second Hospital of Shandong University
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
OESOLUS
University Hospital, Lille
PERIOP-PC
Stanford University
Impact of Arterial Partial Pressure of Oxygen on Anastomotic Leakage After Esophagectomy
Sun Yat-sen University
DELOGAST
University Hospital, Lille
A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)
Merck Sharp & Dohme LLC
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
Hoffmann-La Roche
FAISA-CORPPS
University Hospital, Lille
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
CRISPR Therapeutics
High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients
Zhejiang University
ARION
UNICANCER
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
Laekna Limited
Evaluations of Alcohol Warning Labels
University of Connecticut
ESOCA
AdventHealth
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
Dana-Farber Cancer Institute
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
Dartmouth-Hitchcock Medical Center
HARMONI
Hospices Civils de Lyon
Perioperative Outcomes and Survival of Inflatable Video-Assisted Mediastinoscopic Transhiatal Esophagectomy for Selected Esophageal Cancer
Shanghai Zhongshan Hospital
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals